Evaluation of the anti-inflammatory and anti-tumor effect of Ipomoea obscura (L) and its mode of action through the inhibition of pro inflammatory cytokines, nitric oxide and COX-2

Inflammation

Volumn 34, Issue 3, 2011, Pages 171-183

  Hamsa, T P ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

anti inflammatory agent; anti tumor agent; Ipomoea obscura; lipopolysaccharide; paw edema; proinflammatory cytokine

Indexed keywords

C REACTIVE PROTEIN; CARRAGEENAN; CYTOKINE; DEXTRAN; FORMALDEHYDE; IPOMOEA OBSCURA EXTRACT; LIPOPOLYSACCHARIDE; METHANOL; NITRIC OXIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; EHRLICH ASCITES TUMOR; EHRLICH ASCITES TUMOR CELL; GENE; GENE EXPRESSION; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; IPOMOEA; IPOMOEA OBSCURA; MOUSE; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; SOLID TUMOR; SURVIVAL RATE; TUMOR NECROSIS FACTOR ALPHA GENE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; C-REACTIVE PROTEIN; CELL LINE; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DNA PRIMERS; GENE EXPRESSION; INFLAMMATION; INFLAMMATION MEDIATORS; IPOMOEA; MEDICINE, AYURVEDIC; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

ANIMALIA; IPOMOEA OBSCURA; MUS;

EID: 79956081704     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9221-4     Document Type: Article

References (45)

1. Colditz, I.G. 1985. Margination and emigration of leucocytes. Survey and Synthasis of Pathology Research 4(1): 44-68.
2. Kasama, T., R.M. Strieter, N.W. Lukacs, P.M. Lincoln, M.D. Burdick, and S.L. Kunkel. 1995. Interferon gamma modulates the expression of neutrophil-derived chemokines. Journal of Investigative Medicine 43(1): 58-67.
3. Kasama, T., R.M. Strieter, T.J. Standiford, M.D. Burdick, and S.L. Kunkel. 1993. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. The Journal of Experimental Medicine 178(1): 63-72. (Pubitemid 23173243)
4. Gallin, M., K.J.J. Edmonds, K.D. Ellner, A.T. Erttmann, H.S. Whit, H.R. Newland, Taylor, and B.M. Greene. 1998. Cellmediated immune responses in human infection with Onchocerca volvulus. Journal of Immunology 140(6): 1999-2007.
5. Ohshima, H., M. Tatemichi, and T. Sawa. 2003. Chemical basis of inflammation-induced carcinogenesis. Archives of Biochemistry and Biophysics 417(1): 3-11. (Pubitemid 36960042)
6. Schimmer, B.P., and K.L. Parker. 2001. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In The pharmacological basis of therapeutics, 10th ed, ed. J.G. Hardman, L.E. Limbird, and G.A. Goodman, 1649-1677. New York: McGraw-Hill.
7. Raz, A. 2002. Is inhibition of cyclooxygenase required for the antitumourigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer. Biochemical Pharmacology 63: 343-347. (Pubitemid 34169714)
8. Clark, A.M. 1996. Natural products as resource for new drugs. Pharmaceutical Research 13: 1133-1144.
9. Austin, D.F. 1991. Ipomoea littoralis (Convolvulaceae): taxonomy, distribution and ethnobotany. Economic Botany 45(2): 251-256.
10. Bhattacharya, S.K., K.S. Satyan, and S. Ghosal. 1997. Antioxidant activity of glycowithanolides from Withania somnifera. Indian Journal of Experimenttal Biology 35(3): 236-9. (Pubitemid 28135409)
11. Jennet-Siems, K., R. Weigl, M. Kaloga, J. Schulz, and E. Eich. 2003. Ipobscurine C and D:macrolactum-type indole alkaloids from the seeds of Ipomoea obscura. Phytomedicine 62: 1257-1263. (Pubitemid 36383598)
12. Paula, A.C.B., L.S.S. Hayashi, and J.C. Freitas. 2003. Antiinflammatory and antispasmodic activity of Ipomoea imperati (Vahl) Griseb (Convolvulaceae). Brazilian Journal of Medical and Biological Research 36(1): 105-112. (Pubitemid 36231199)
13. Fosberg, F.R., and M.H. Sachet. 1977. Convolvulaceae. Flora of Micronesia, 3. Smithsonian Contribution to Botany 36: 1-3.
14. Pongprayoon, U., P. Baeckstrom, and U. Jacobsson. 1992. Antispasmodic activity of beta-damascenone and E-phytol isolated from Ipomoea pescaprae. Planta Medica 58: 19-21.
15. Hamsa, T.P., and G. Kuttan. 2008. Ipomoea Obscura (L.) enhances the functions of immunological effector cells inhibits proinflammatory cytokines and nitric oxide production by LPS induced macrophages. Immunopharmacology and Immunotoxicology 16: 1-15.
16. Langrange, P.H., G.B.Mackaness, and T.E. Miller. 1974. Influence of dose and route of antigen injection on the immunological induction of T cells. The Journal of Experimental Medicine 139(3): 528-42.
17. Zhou, J.Y., F.D. Tang, G.G. Mao, and R.L. Bian. 2004. Effect of alpha-pinene on nuclear translocation of NF-kappa B in THP-1 cells. Acta Pharmacologica Sinica 25: 480-484.
18. Winter, C.A., E.A. Risly, and C.W. Nuss. 1962. Carrageenan induced edema in hind paw of the rats - an assay for antiinflammatory drugs. Proceeding of the Society for Experimental Biology and Medicine 111: 544-547.
19. Maity, T.K., S.C. Mandal, and P.K. Mukherjee. 1998. Studies on anti-inflammatory effect of Cassia tora leaf extract (Fam. Leguminosae). Phytotherapy Research 12: 221-223. (Pubitemid 28202106)
20. Chau, T.T. 1989. Analgesic testing in animal models in pharmacological methods in the control of inflammations, 448. New York: Alan R Liss Inc.
21. Cole, S.P.C. 1986. Rapid chemosensitivity testing of human lung tumour cells using MTT assay. Cancer Chemotherapy and Pharmacology 17: 259-63. (Pubitemid 16070936)
22. Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry 126 (1): 131-8. (Pubitemid 13203451)
23. Talwar, G.P. 1974. In Hand book of practical immunology, ed. G.P. Talwar, 339-336. New Delhi: National Book Trust.
24. Atia, M.A., and D.W. Weiss. 1966. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumour resistance and enhancement in strain A mice infected with mammary tumour virus. Cancer Research 26: 1787-1900.
25. Sugarman, B.J., B.B. Agarwal, P.E. Hass, I.S. Figari, M.A. Palladino, and H.M. Shepard. 1985. Recombinant tumour necrosis factor cells in vitro. Science 230: 943-945.
26. Tomkins, P., K. Cooper, D. Webber, and G. Bower. 1992. The L929 cell bioassay for murine tumour necrosis factor is not inXuenced by other cytokines. Journal of Immunological Methods 15: 313-315.
27. Aggarwal, B.B., S. Shishodia, S.K. Sandur, M.K. Pandey, and G. Sethi. 2006. Inflammation and cancer: how hot is the link? Biochemical Pharmacology 72: 1605-1621.
28. Vinegar, R., W. Schreiber, and R.J. Hugo. 1969. Biphasic development of carrageenin edema in rats. The Journal of Pharmacology and Experimental Therapeutics 166: 96-103.
29. Akkol, E.K., F.N. Yalçin, D. Kaya, I. Calis, E. Yesilada, and T. Ersöz. 2008. In vivo anti-inflammatory and antinociceptive actions of some Lamium species. Journal of Ethnopharmacology 118: 166-172.
30. Tanas, S., F. Odabasoglu, Z. Halici, A. Cakir, H. Aygun, A. Aslan, and H. Suleyman. 2010. Evaluation of anti-inflammatory and antioxidant activities of Peltigera rufescens lichen species in acute and chronic inflammation models. Journal of Natural Medicines 64: 42-9.
31. Park, H.J., I.T. Kim, J.H. Won, S.H. Jeong, E.Y. Park, J.H. Nam, J. Choi, and K.T. Lee. 2007. Anti-inflammatory activities of ent-16αH, 17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX- 2 expression in RAW 264.7 macrophages via NF-B inactivation. European Journal of Pharmacology 558: 185-193. (Pubitemid 46328868)
32. Ramprasath, V.R., P. Shanthi, and P. Sachdanandam. 2004. Antiinflammatory Effect of Semecarpus anacardium LINN. Nut extract in acute and chronic inflammatory conditions. Biological & Pharmaceutical Bulletin 27: 2028-2031.
33. Heiss, E., C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhauser. 2001. Nuclear factor Kappa B is a molecular target for sulforaphane- mediated anti-inflammatory mechanisms. The Journal of Biological Chemistry 276: 32008-15.
34. Kuo, P.C., and R.A. Schroeder. 1995. The emerging multifaceted roles of nitric oxide. Annals of Surgery 221: 220-35.
35. Palladino, M.A., F.R. Bahjat, E.A. Theodorakis, and L.L. Moldawer. 2003. Anti-TNFalpha therapies: the next generation. Nature Reviews. Drug Discovery 2: 736-46.
36. Tsuzaki, M., G. Guyton, W. Garrett, J.M. Archambault, W. Herzog, L. Almekinders, D. Bynum, X. Yang, and A.J. Banes. 2003. IL-1 β induces COX2, MMP-1, -3 and -13, DAMTS-4, IL-1 β and IL-6 in human tendon cells. Journal of Orthopaedic Research 21: 256-264. (Pubitemid 36322545)
37. Krishnamoorthy, S., and K.V. Honn. 2006. Inflammation and disease progression. Cancer and Metastasis Reviews 25: 481-491. (Pubitemid 44922363)
38. Ames, B.M., G.L. Swirsky, and W.C. Willet. 1995. The causes and prevention of cancer. Proceedings of the National Academy of Science 92: 5258-5265.
39. Bose, M., and P. Farnia. 1995. Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process. Immunology Letters 48: 59-64. (Pubitemid 26011520)
40. Sachter, F., E.J. Beecham, J.M. Covey, K.W. Kohn, and M. Potter. 1988. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis 9: 2297-2304. (Pubitemid 19001335)
41. Jiau-Jian, L., and W.O. Larry. 1977. Over expression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumour necrosis factor α and/or hyperthermia. Cancer Research 57: 1991-1998.
42. Ruby, A.J., G. Kuttan, K.B. Dinesh, K.N. Rajasekharanb, and R. Kuttan. 1995. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters 94: 79-83.
43. Ming, L., C.P. Jill, J.N. Jingfang, C. Edward, and E. Brash. 1998. Antioxidant action via p53-mediated apoptosis. Cancer Research 58: 1723-1729.
44. Putul, M., C. Sunit, and B. Pritha. 2000. Neovascularisation offers a new perspective to glutamine-related therapy. Indian Journal of Experimental Biology 38: 88-90.
45. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539-45.